Trial · NCT03488251
Adverse events384
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 384
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nausea | Gastrointestinal disorders | Part 1: Cohort 1: MT-3724 10 mcg/kg/ GEM/ OX | 7 | 8 | |
| other | Nausea | Gastrointestinal disorders | Part 1: Cohort 2: MT-3724 25 mcg/kg/ GEM/ OX | 0 | 0 | |
| other | Nausea | Gastrointestinal disorders | Part 1: Cohort 3: MT-3724 50 mcg/kg/ GEM/ OX | 0 | 0 | |
| other | Nausea | Gastrointestinal disorders | Part 2: MT-3724/ GEM/ OX | 0 | 0 | |
| other | Diarrhea | Gastrointestinal disorders | Part 1: Cohort 1: MT-3724 10 mcg/kg/ GEM/ OX | 3 | 8 | |
| other | Diarrhea | Gastrointestinal disorders | Part 1: Cohort 2: MT-3724 25 mcg/kg/ GEM/ OX | 0 | 0 | |
| other | Diarrhea | Gastrointestinal disorders | Part 1: Cohort 3: MT-3724 50 mcg/kg/ GEM/ OX | 0 | 0 | |
| other | Diarrhea | Gastrointestinal disorders | Part 2: MT-3724/ GEM/ OX | 0 | 0 | |
| other | Abdominal pain | Gastrointestinal disorders | Part 1: Cohort 1: MT-3724 10 mcg/kg/ GEM/ OX | 2 | 8 | |
| other | Abdominal pain | Gastrointestinal disorders | Part 1: Cohort 2: MT-3724 25 mcg/kg/ GEM/ OX | 0 | 0 | |
| other | Abdominal pain | Gastrointestinal disorders | Part 1: Cohort 3: MT-3724 50 mcg/kg/ GEM/ OX | 0 | 0 | |
| other | Abdominal pain | Gastrointestinal disorders | Part 2: MT-3724/ GEM/ OX | 0 | 0 | |
| other | Constipation | Gastrointestinal disorders | Part 1: Cohort 1: MT-3724 10 mcg/kg/ GEM/ OX | 2 | 8 | |
| other | Constipation | Gastrointestinal disorders | Part 1: Cohort 2: MT-3724 25 mcg/kg/ GEM/ OX | 0 | 0 | |
| other | Constipation | Gastrointestinal disorders | Part 1: Cohort 3: MT-3724 50 mcg/kg/ GEM/ OX | 0 | 0 | |
| other | Constipation | Gastrointestinal disorders | Part 2: MT-3724/ GEM/ OX | 0 | 0 | |
| other | Vomiting | Gastrointestinal disorders | Part 1: Cohort 1: MT-3724 10 mcg/kg/ GEM/ OX | 2 | 8 | |
| other | Vomiting | Gastrointestinal disorders | Part 1: Cohort 2: MT-3724 25 mcg/kg/ GEM/ OX | 0 | 0 | |
| other | Vomiting | Gastrointestinal disorders | Part 1: Cohort 3: MT-3724 50 mcg/kg/ GEM/ OX | 0 | 0 | |
| other | Vomiting | Gastrointestinal disorders | Part 2: MT-3724/ GEM/ OX | 0 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03488251/events